Atlas FDA

SUPARTZ

FDA premarket approval P980044/S003 · decided 2006-01-20

Approval details

PMA number
P980044
Supplement
S003
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
SUPARTZ
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2004-09-14
Decision date
2006-01-20
Days to decision
493 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
APPROVAL FOR LABELING CHANGES INCLUDING MODIFYING THE DIRECTIONS FOR USE SECTION TO INCLUDE A STATEMENT REGARDING THE USE OF A COURSE OF 3 INJECTIONS, AND ADDING INFORMATION ABOUT ADVERSE EVENTS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15